Pelvic abscess associated with Actinomyces species ‒ a rare post-cesarean complication

IF 0.1 Q4 OBSTETRICS & GYNECOLOGY

Case Reports in Perinatal Medicine Pub Date : 2022-01-01 DOI:10.1515/crpm-2021-0048

Yuping Wang, S. Ferrero, Shasha Li, Shisan Liu, Wah Yang

引用次数: 0

Abstract

Abstract Objectives Pelvic actinomycotic abscess is uncommon and its presentation as a post-cesarean complication may be confused with hemorrhagic mass. It is still a disease that poses a significant diagnostic challenge. Management and prognosis are not well known for this type of infection. Case presentation A 36-year-old woman was admitted to the hospital six days after the cesarean section with abdominal pain and dysuria. The second operation was diagnosed as pelvic abscess, debridement and drainage about 250 mL abscess. Bacterial culture of abscess confirmed as Actinomyces odontolyticus infection. Intravenous penicillin was given immediately, amoxicillin was taken orally for three months after discharge, and no recurrence was found after follow-up for ten months. Conclusions Pelvic A. odontolyticus abscess may be confirmed through correct bacterial culture and cured by a short-term course of Amoxicillin. With prompt recognition and treatment, favorable outcomes of pelvic Actinomycotic abscess in the perinatal period could be achieved.

查看原文本刊更多论文

盆腔脓肿与放线菌有关-一种罕见的剖宫产后并发症

摘要目的盆腔放线菌性脓肿并不常见，其作为剖宫产后并发症的表现可能与出血性肿块相混淆。它仍然是一种对诊断构成重大挑战的疾病。这种感染的治疗和预后尚不清楚。病例介绍一名36岁妇女剖宫产术后6天因腹痛和排尿困难入院。第二次手术诊断为盆腔脓肿，清创引流脓肿约250 mL。脓肿细菌培养证实为溶牙放线菌感染。出院后立即静脉滴注青霉素，口服阿莫西林3个月，随访10个月无复发。结论盆腔溶牙原体脓肿可通过正确的细菌培养确诊，并经短期阿莫西林治疗。围生期盆腔放线菌性脓肿及时识别和治疗，可获得良好的预后。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Case Reports in Perinatal Medicine OBSTETRICS & GYNECOLOGY-

自引率

0.00%

发文量

期刊介绍： Case Reports in Perinatal Medicine is a double-blind peer-reviewed journal. The objective of the new journal is very similar to that of JPM. In addition to evidence-based studies, practitioners in clinical practice esteem especially exemplary reports of cases that reveal specific manifestations of diseases, its progress or its treatment. We consider case reports and series to be brief reports describing an isolated clinical case or a small number of cases. They may describe new or uncommon diagnoses, unusual outcomes or prognosis, new or infrequently used therapies and side effects of therapy not usually discovered in clinical trials. They represent the basic concept of experiences for studies on representative groups for further evidence-based research. The potential roles of case reports and case series are: Recognition and description of new diseases Detection of drug side effects (adverse or beneficial) Study of mechanisms of disease Medical education and audit Recognition of rare manifestations of disease.